A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Fluoroquinolones; Gatifloxacin; Moxifloxacin; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• diagnosed with bacterial conjunctivitis

Exclusion Criteria:

• chemical or foreign body trauma to either eye

• infection in either eye (besides bacterial conjunctivitis)

• white spots in the cornea or ulcers in either eye

• clinical diagnosis of chlamydia or gonorrhea in either eye